NICE guidelines recommend GLP-1 receptor agonists for specific patient populations with type 2 diabetes
[13] [14] By activating these three pathways together, retatrutide is thought to produce effects on appetite suppression and blood glucose regulation
This gradual escalation approach is broadly consistent with titration strategies used for other GLP-1-based therapies already authorised in the UK, such as semaglutide (Wegovy) and tirzepatide (Mounjaro), both of which are subject to NICE technology appraisal guidance and NHS prescribing frameworks
doi:10.1155/2014/289264 [24] Zamani M, Zarei M, Nikbaf-Shandiz M, Hosseini S, Shiraseb F, Asbaghi O
Tirzepatide (Zepbound / Mounjaro) Tirzepatide is the closest available drug to retatrutide
Two to three resistance training sessions per week, using body weight exercises, resistance bands, or light weights, can substantially reduce muscle loss during weight loss